Mechanisms by which chemokine CXCL12 functions in hematopoiesis and lymphopoiesis

趋化因子CXCL12在造血和淋巴细胞生成中的作用机制

基本信息

  • 批准号:
    15390160
  • 负责人:
  • 金额:
    $ 9.79万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

CXC chemokine ligand (CXCL)12 (stromal cell-derived factor (SDF-1)/pre-B-cell-growth-stimulating factor(PBSF)) and its primary physiologic receptor CXCR4 are essential for B cell development and colonization of bone marrow by hematopoietic cells during. In this study, we have analyzed further the roles of CXCL12 in mobilization of hematopoietic cells between and within hematopoietic organs. (1)Hematopoietic stem cells(HSCs) are mobile and sequence of hematopoietic colonization events occurs during ontogeny. We have shown that CXCL12 plays a critical role in homing of HSCs and myeloid cells to bone marrow from the peripheral circulation using a long-term repopulation assay and cell homing assay. (2)B lymphocytes are generated from HSCs and develop within bone marrow and dependency on CXCL12 appears at the earliest stages, pre-pro-B cells. We have found that CXCL12-expressing cells are a small population of stromal cells, had several processes, are scattered throughout bone marrow and located some distance from the cells expressing interleukin (IL)-7. Multipotent hematopoietic progenitors are attached to the processes of CXCL12-expressing cells and pre-pro-B cells adjoin their cell bodies. Maturer pro-B cells, which require IL-7, have moved away and adjoin the IL-7-expressing cells. Maturer pre-B cells are not in contact with IL-7-expressing cells. Furthermore, the end-stage B cells, plasma cells again seed CXCL12-expressing cells. Thus, we have identified stage-specific niches for B lymphopoiesis, demonstrated the B lymphocyte characteristic location and movement between specific niches within bone marrow during development and suggested that CXCL12 maintains the precursors in the niche. Together, CXCL12 is likely to play a critical role in the interaction of hematopoictic cells with the specific cellular niches in bone marrow.
CXC趋化因子配体(CXCL)12(基质细胞衍生因子(SDF-1)/前B细胞生长刺激因子(PBSF))及其主要生理受体CXCR 4是造血干细胞在B细胞发育和骨髓定植过程中所必需的。在这项研究中,我们进一步分析了CXCL 12在造血器官之间和造血器官内造血细胞动员中的作用。(1)造血干细胞(HSCs)是移动的,在个体发育过程中发生一系列造血定植事件。我们已经使用长期再增殖测定和细胞归巢测定表明,CXCL 12在造血干细胞和骨髓细胞从外周循环归巢至骨髓中起关键作用。(2)B淋巴细胞由HSC产生并在骨髓内发育,对CXCL 12的依赖性出现在最早期,即前原B细胞。我们发现CXCL 12表达细胞是一小群基质细胞,有几个突起,分散在整个骨髓中,与表达白细胞介素(IL)-7的细胞有一定距离。多能造血祖细胞附着于表达CXCL 12的细胞的突起,前原B细胞邻接它们的细胞体。需要IL-7的成熟前B细胞已经离开并邻接表达IL-7的细胞。成熟的前B细胞不与表达IL-7的细胞接触。此外,终末期B细胞、浆细胞再次接种表达CXCL 12的细胞。因此,我们已经确定了B淋巴细胞生成的阶段特异性小生境,证明了B淋巴细胞在发育过程中在骨髓内特定小生境之间的特征性位置和运动,并表明CXCL 12维持小生境中的前体。总之,CXCL 12可能在造血细胞与骨髓中特定细胞龛的相互作用中发挥关键作用。

项目成果

期刊论文数量(38)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ara, T., Tokoyoda, K.Sugiyama, T., Egawa, T., Kawabata, K., Nagasawa, T.: "Long-term hematopoietic stem cells require stromal cell-derived fadtor-1 for colonizaing bone marrow during ontogeny"Immunity. 19・2. 257-267 (2003)
Ara, T.、Tokoyoda、K.Sugiyama, T.、Egawa, T.、Kawabata, K.、Nagasawa, T.:“长期造血干细胞需要基质细胞衍生的 fadtor-1 在个体发育过程中定植于骨髓《免疫.19・2.257-267(2003)》
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
The role of CXCL12 in the organ-specific process of artery formation
  • DOI:
    10.1182/blood-2004-07-2563
  • 发表时间:
    2005-04-15
  • 期刊:
  • 影响因子:
    20.3
  • 作者:
    Ara, T;Tokoyoda, K;Nagasawa, T
  • 通讯作者:
    Nagasawa, T
動脈内皮細胞の判別方法
如何识别动脉内皮细胞
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Stumm, R., Zhou, C., Ara, T., Lazarini, F, Dubois-Dalcq, M., Nagasawa, T., Hollt, V., Schulz, S.: "CXCR4 regulates interneuron migration in the developing neocortex"J.Neurosci.. 23・12. 5123-5130 (2003)
Stumm, R.、Zhou, C.、Ara, T.、Lazarini, F、Dubois-Dalcq, M.、Nagasawa, T.、Holt, V.、Schulz, S.:“CXCR4 调节发育中的新皮质中的中间神经元迁移《神经科学杂志》23・12. 5123-5130 (2003)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
A role of CXCL12/SDF-1/PBSF and its receptor CXCR4 in fetal and adult T cell development in vivo.
CXCL12/SDF-1/PBSF 及其受体 CXCR4 在胎儿和成人 T 细胞体内发育中的作用。
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ara;T.
  • 通讯作者:
    T.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NAGASAWA Takashi其他文献

NAGASAWA Takashi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NAGASAWA Takashi', 18)}}的其他基金

Regulation of protein synthesis and degradation in skeletal muscle by amino acids which are not used for protein synthesis
通过不用于蛋白质合成的氨基酸调节骨骼肌中的蛋白质合成和降解
  • 批准号:
    24614002
  • 财政年份:
    2012
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The regulation of lympho-hematopoiesis by bone marrow niches
骨髓生态位对淋巴造血的调节
  • 批准号:
    22390096
  • 财政年份:
    2010
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A Study of the Cross-cultural Influences Between Byzantine Art andWestern Medieval Art in the 12th and 13th Centuries
12、13世纪拜占庭艺术与西方中世纪艺术的跨文化影响研究
  • 批准号:
    22401020
  • 财政年份:
    2010
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Anti-stress amino acids and its mechanisms in muscle atrophy
抗应激氨基酸及其在肌肉萎缩中的作用机制
  • 批准号:
    21580134
  • 财政年份:
    2009
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Different response of amino acids on muscle protein synthesis and degradation under nutritional stresses
营养应激下氨基酸对肌肉蛋白质合成和降解的不同反应
  • 批准号:
    18580110
  • 财政年份:
    2006
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The spatiotemporal regulation of cell behavior in lymphohe matopoiesis by environmental factors within bone marrow
骨髓内环境因素对淋巴造血细胞行为的时空调节
  • 批准号:
    17209019
  • 财政年份:
    2005
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Dynamics of extracellular environments
细胞外环境的动力学
  • 批准号:
    17082001
  • 财政年份:
    2005
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
The role of chemokine CXCL12 and CXCL12 abundant reticular cells in formation of microenvironmental niches for hematopoiesis
趋化因子CXCL12和CXCL12丰富的网状细胞在造血微环境生态位形成中的作用
  • 批准号:
    17082002
  • 财政年份:
    2005
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Physiologic and pathologic functions of a CXC chemokine PBSF/SDF-1 and its receptor CXCR4
CXC趋化因子PBSF/SDF-1及其受体CXCR4的生理和病理功能
  • 批准号:
    10470092
  • 财政年份:
    1998
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Factor of suppression of tissue protein degradation after feeding and its mechanism
饲后组织蛋白降解抑制因素及其机制
  • 批准号:
    09660126
  • 财政年份:
    1997
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Regulation of chemokine receptor signaling
趋化因子受体信号传导的调节
  • 批准号:
    10622915
  • 财政年份:
    2023
  • 资助金额:
    $ 9.79万
  • 项目类别:
Mechanism of metastatic control by chemokine receptor ACKR3
趋化因子受体ACKR3控制转移的机制
  • 批准号:
    23K06639
  • 财政年份:
    2023
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulation of Melanoma Cell Malignancy by Compartmentalized Chemokine Receptor Signaling
通过区室化趋化因子受体信号传导调节黑色素瘤细胞恶性肿瘤
  • 批准号:
    10528741
  • 财政年份:
    2022
  • 资助金额:
    $ 9.79万
  • 项目类别:
Development of second-generation radiopharmaceuticals targeting the C-X-C chemokine receptor 4 for imaging and therapy of hematological cancers
开发针对 C-X-C 趋化因子受体 4 的第二代放射性药物,用于血液癌症的成像和治疗
  • 批准号:
    463499
  • 财政年份:
    2022
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Operating Grants
Understanding the impact of AAK1 on T cell chemokine receptor expression and chemotaxis
了解 AAK1 对 T 细胞趋化因子受体表达和趋化性的影响
  • 批准号:
    10300774
  • 财政年份:
    2021
  • 资助金额:
    $ 9.79万
  • 项目类别:
Bi-directional regulation of chemokine receptor signaling
趋化因子受体信号传导的双向调节
  • 批准号:
    10795393
  • 财政年份:
    2021
  • 资助金额:
    $ 9.79万
  • 项目类别:
Bi-directional regulation of chemokine receptor signaling
趋化因子受体信号传导的双向调节
  • 批准号:
    10646415
  • 财政年份:
    2021
  • 资助金额:
    $ 9.79万
  • 项目类别:
Inhibition of COPD development by inhibiting chemokine receptor CCR4 function.
通过抑制趋化因子受体 CCR4 功能来抑制 COPD 的发展。
  • 批准号:
    21K20857
  • 财政年份:
    2021
  • 资助金额:
    $ 9.79万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Chemokine-receptor profiling for painful diabetic neuropathy in biological samples from human clinical trials
人体临床试验生物样本中疼痛性糖尿病神经病变的趋化因子受体分析
  • 批准号:
    10326651
  • 财政年份:
    2021
  • 资助金额:
    $ 9.79万
  • 项目类别:
Optimization of a Chemokine Receptor Antagonist Peptide as a Synapse Protecting Treatment for Neurodegeneration in Alzheimer's Disease
趋化因子受体拮抗剂肽的优化作为阿尔茨海默病神经变性的突触保护治疗
  • 批准号:
    10322074
  • 财政年份:
    2021
  • 资助金额:
    $ 9.79万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了